AstraZeneca takes $6m hit after 'faking conferences' to bribe doctors | London Evening Standard | Evening Standard

archive.today
webpage capture

Saved from

no other snapshots from this url |

24 Mar 2021 21:20:44 UTC

All snapshots | from host www.standard.co.uk
Webpage Screenshot
share download .zip report bug or abuse donate

BREAKING
9h Exclusive: Barrister whose dog mauled Freddie the seal - I apologise unreservedly
5h Police make arrest after bomb disposal team call to Queen’s residence
6h Prince Harry confirms second job in 48 hours
1h UK and EU resolve to settle vaccines dispute with ‘win-win’ deal
2h Pubs may ban customers who haven’t had Covid vaccine, says PM
1h School changing back name to honour Spitfire pilot who saved pupils

# AstraZeneca takes $6m hit after 'faking conferences' to bribe doctors

AstraZeneca is one of the biggest international pharma firms in China with 45,000 staff
By
By Lucy Tobin |
31 August 2016
A
straZeneca today coughed up $5.5 million (£4.2 million) to settle a highly embarrassing foreign bribery probe, amid claims that the British pharma giant faked conferences and offered gifts to local doctors in Russia and China who bought its drugs.
Britain’s number two drugmaker — one of the biggest international pharma firms in China, with 45,000 staff — falsely recorded improper payments in China and Russia as bona fide business expenses, the US Securities and Exchange Commission said. Some bribery allegations go back as far as 2005, with AstraZeneca said to have made “improper payments of gifts, conference support, travel, cash and other benefits” mainly to Chinese and Russian state medical workers “to reward or influence” their purchases of its drugs.
The SEC claims AstraZeneca set up bank accounts in doctors’ names, hired a “collusive travel vendor” who submitted fake or inflated invoices to generate cash to funnel money, and “totally fabricated” conferences to pay out speaker fees despite there being “no meeting date, venue, [nor] subject”.
Some employees at AstraZeneca in China also paid cash to local officials to reduce or avoid local fines, and even created written charts and schedules about predicted or actual bribe payments, the SEC said.
These were either offered to individual doctors, or to particular hospitals or medical departments, “with the expectation that the [medical staff] would increase purchases of Astra’s products during the corresponding period, or favourably influence the inclusion of [Astra’s] products on formulary or reimbursement drug listings,” according to the SEC.
AstraZeneca, which co-operated with the probe, neither admitted nor denied wrongdoing. It said the US Justice Department has, meanwhile, closed a related foreign bribery investigation. “We are pleased to have resolution of these matters,” the company said.
The US watchdog said AstraZeneca had tackled problems with its compliance and fired some staff involved.
MORE ABOUT AstraZeneca China
Comments
Reuse content

## Conversation Discussion

|

### All Comments

Start The Conversation
ADVERTISEMENT

## Trending

- 1Barrister whose dog mauled Freddie the seal: I apologise unreservedly
- 2PMQs verdict: Keir Starmer skewers Boris Johnson on armed forces cuts
- 3Babysitter found guilty of murdering ‘happy’ toddler
- 4PM blow to summer holidaymakers as EU and UK seek to cool vaccine row
- 5UK records 98 further coronavirus deaths and 5,605 cases

ADVERTISEMENT
ADVERTISEMENT

0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%